BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $527,000 | -57.8% | 5,990 | -53.4% | 0.18% | -4.7% |
| Q1 2021 | $1,249,000 | +27.6% | 12,843 | +47.2% | 0.19% | +38.8% |
| Q4 2020 | $979,000 | +26.2% | 8,727 | +4.3% | 0.14% | +3.0% |
| Q3 2020 | $776,000 | -22.9% | 8,369 | -35.1% | 0.14% | -32.2% |
| Q2 2020 | $1,007,000 | +226.9% | 12,905 | +145.3% | 0.20% | -21.0% |
| Q1 2020 | $308,000 | -20.8% | 5,261 | +8.3% | 0.25% | +342.1% |
| Q4 2019 | $389,000 | -53.1% | 4,859 | -57.0% | 0.06% | -70.2% |
| Q3 2019 | $830,000 | -16.5% | 11,291 | +7.1% | 0.19% | +2.1% |
| Q2 2019 | $994,000 | – | 10,541 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
| BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
| Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
| Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
| PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
| Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
| Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
| Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
| Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |